T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
RingCentral
RNG
$5.25B
| $6.37M | ﹤0.01% |
159,381
-5,330
| -3% | -$256K |
|
1152
Fidelity National Financial
FNF
$12.8B
| $6.36M | ﹤0.01% |
182,820
+1,818
| +1% | +$67.9K |
|
1153
XPeng
XPEV
$11.3B
| $6.35M | ﹤0.01% |
531,662
+516,262
| +3,352% | +$11.1M |
|
|
UNVR
1154
DELISTED
Univar Solutions Inc.
UNVR
| $6.33M | ﹤0.01% |
278,524
-3,345,181
| -92% | -$84M |
|
1155
Toyota
TM
$223B
| $6.3M | ﹤0.01% |
48,321
+29,434
| +156% | +$4.46M |
|
1156
NeoGenomics
NEO
$2.11B
| $6.27M | ﹤0.01% |
727,588
-844,425
| -54% | -$8.39M |
|
|
RENT
1157
Rent the Runway
RENT
$119M
| $6.24M | ﹤0.01% |
141,882
-224,785
| -61% | -$18.5M |
|
1158
Norwegian Cruise Line
NCLH
$8.69B
| $6.18M | ﹤0.01% |
544,219
+3,825
| +0.7% | +$50.4K |
|
1159
Tenaya Therapeutics
TNYA
$164M
| $6.13M | ﹤0.01% |
2,114,252
-1,252,528
| -37% | -$5.85M |
|
|
SIX
1160
DELISTED
Six Flags Entertainment Corp.
SIX
| $6.11M | ﹤0.01% |
345,319
-88,027
| -20% | -$1.99M |
|
1161
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $6.02M | ﹤0.01% |
74,085
+8,200
| +12% | +$675K |
|
|
AL
1162
DELISTED
Air Lease Corp
AL
| $5.98M | ﹤0.01% |
192,779
-3,444,126
| -95% | -$123M |
|
1163
Cadre Holdings
CDRE
$1.44B
| $5.97M | ﹤0.01% |
248,072
-942,897
| -79% | -$23.1M |
|
1164
Gaming and Leisure Properties
GLPI
$12.5B
| $5.95M | ﹤0.01% |
134,527
+2,767
| +2% | +$137K |
|
1165
Advanced Drainage Systems
WMS
$11.3B
| $5.92M | ﹤0.01% |
47,596
-39,604
| -45% | -$4.93M |
|
1166
Regenxbio
RGNX
$720M
| $5.84M | ﹤0.01% |
221,052
+1,146
| +0.5% | +$34K |
|
1167
Kodiak Sciences
KOD
$2.72B
| $5.77M | ﹤0.01% |
745,979
+89,561
| +14% | +$870K |
|
1168
ADC Therapeutics
ADCT
$134M
| $5.74M | ﹤0.01% |
1,190,754
-770,456
| -39% | -$5.58M |
|
|
PPBI
1169
DELISTED
Pacific Premier Bancorp
PPBI
| $5.73M | ﹤0.01% |
185,134
-5,162,888
| -97% | -$168M |
|
|
PCH
1170
DELISTED
PotlatchDeltic
PCH
| $5.72M | ﹤0.01% |
139,467
-1,830,560
| -93% | -$84.1M |
|
1171
Okta
OKTA
$26.9B
| $5.67M | ﹤0.01% |
99,787
-12,733,917
| -99% | -$1.1B |
|
|
LIAN
1172
DELISTED
LianBio American Depositary Shares
LIAN
| $5.62M | ﹤0.01% |
2,822,857
+695,979
| +33% | +$1.66M |
|
|
LBPH
1173
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $5.62M | ﹤0.01% |
1,509,775
-1,964
| -0.1% | -$7.25K |
|
|
RXDX
1174
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $5.61M | ﹤0.01% |
+95,089
| New | +$4.35M |
|
1175
American Financial Group
AFG
$12B
| $5.61M | ﹤0.01% |
45,588
+6,507
| +17% | +$854K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.